Clinical Trial Detail

NCT ID NCT01972516
Title Tivozanib As Maintenance Therapy In GYN
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements no
Sponsors Dana-Farber Cancer Institute
Indications

fallopian tube cancer

ovarian cancer

peritoneum cancer

Therapies

Tivozanib

Age Groups: adult

No variant requirements are available.